Director/PDMR Shareholding

9 Dec 2005 17:46

Akers Biosciences, Inc.09 December 2005 AKERS BIOSCIENCES, INC. ISSUE OF EQUITY Akers Biosciences, Inc. today announces that on 6 December 2005 it approved theissue of 28,000 shares of common stock, no par value ("Common Shares") to DavidWilbraham, non-executive chairman, which represents 0.05% of the total sharecapital. The shares will be issued in lieu of unpaid directors' fees andexpenses in the amount of £19,740. The price per share for this transaction was70.5 pence. Following this purchase, Mr. Wilbraham is the beneficial owner of 350,000 commonshares representing 0.64% of the issued capital. Application has been made to the London Stock Exchange for the 28,000 CommonShares to be admitted to trading, such admission expected to take place on 14December 2005. Contact: Paul B. Freedman - 00 1 856 848 2116 9 December 2005 End This information is provided by RNS The company news service from the London Stock Exchange